Close

Professor Haleema Shakur-Still

Professor
& CTU Co-Director

Room
Room 132, Senate House

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
+44(0)20 7958 8113

I am Professor of Global Health Clinical Trials and Co-Director of LSHTM's Clinical Trials Unit.

Affiliations

Faculty of Epidemiology and Population Health
Department of Population Health

Centres

Centre for Evaluation
Centre for Maternal Adolescent Reproductive & Child Health (MARCH)

Teaching

I am a tutor on the Distance Learning MSc Clinical Trials and Module Organiser Organiser (www.lshtm.ac.uk/prospectus/masters/dmsct.html

I currently have doctoral students working on the mechanism of action of tranexamic acid on traumatic brain injury and comparison oftreatment strategies for using tranexamic acid in bleeding trauma patients.

Research

I work with an amazing network of collaborators here at LSHTM and in over 50 countries worldwide (see  http://ctu.lshtm.ac.uk/). I am interested in designing and conducting clinical trials that allow for critically ill patients for to benefit for scientific advances. I have a special interest in finding effective interventions for improving Maternal Health, injuries and haemorrhage. I am aslo interested in developing novel ways of communicating the work we do to clinicians, policy makers and the wider public to make sure patients benefit from the results of our research.

Research Area
Clinical care
Clinical trials
Drug discovery and development
Health outcomes
Maternal health
Pharmacovigilance
Systematic reviews
Critical care
Ethics
Evidence use
Medicines
Randomised controlled trials
Reproductive health
Discipline
Epidemiology
Pharmacology
Disease and Health Conditions
Cardiovascular disease
Injuries
Asthma
Neglected Tropical Diseases (NTDs)
Respiratory disease
Country
Afghanistan
Albania
United Arab Emirates
Argentina
Australia
Belgium
Burkina Faso
Bangladesh
Brazil
Canada
China
Cote d'Ivoire
Cameroon
Democratic Republic of the Congo
Colombia
Costa Rica
Cuba
Czech Republic
Germany
Ecuador
Spain
Estonia
France
United Kingdom
Georgia
Ghana
Indonesia
India
Ireland
Iran
Iraq
Italy
Jamaica
Japan
Kenya
Sri Lanka
Mexico
Myanmar (Burma)
Malaysia
Nigeria
Nepal
New Zealand
Pakistan
Peru
Romania
Saudi Arabia
Sudan
El Salvador
Slovakia
Thailand
Tunisia
Tanzania
Uganda
South Africa
Zambia
Region
World

Selected Publications

Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial
Mahmood A; Needham K; Shakur-Still H; Davies D; Belli A; Jamaluddin SF; Harris T; Mohamed FL; Leech C; Lotfi H
2020
European Journal of Trauma and Emergency Surgery
Antifibrinolytic drugs for treating primary postpartum haemorrhage.
Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
2018
The Cochrane database of systematic reviews
Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial
Shakur-Still H; Roberts I; Fawole B; Kuti M; Olayemi O; Bello A; Huque S; Ogunbode O; Kotila T; Aimakhu C
2018
Wellcome Open Research
Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial.
Shakur-Still H; Roberts I; Fawole B; Kuti M; Olayemi OO; Bello A; Huque S; Ogunbode O; Kotila T; Aimakhu C
2018
Wellcome open research
Effects of tranexamic acid on platelet function and thrombin generation (ETAPlaT): WOMAN trial sub-study.
Dallaku K; Shakur H; Roberts I; Edwards P; Beaumont D; Delius M; Siegmund B; Gliozheni O; Tasha I; Cenameri S
2016
Scientific reports
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
CRASH-2 collaborators; Roberts I; Shakur H; Afolabi A; Brohi K; Coats T; Dewan Y; Gando S; Guyatt G; Hunt BJ
2011
Lancet
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H; Roberts I; Bautista R; Caballero J; Coats T; Dewan Y; El-Sayed H; Gogichaishvili T; Gupta S
2010
Lancet
See more Publications